A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis
19h agoen
From the article
Conditions : AD Interventions : Drug: SSGJ-716; Drug: Placebo Sponsors : Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Recruiting
Continue reading on clinicaltrials.gov
Comments
Sign in to join the conversation.
No comments yet. Be the first.